PRECISION OPTICS CORPORATION, INC. (POCI) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
48/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinPOCI / S&P 16.17% / 15.20% |
LosePOCI / S&P POCI unavailable / 15.00% |
LosePOCI / S&P POCI unavailable / 50.40% |
| 2026-Q12/3 |
WinPOCI / S&P 4.77% / -4.33% |
WinPOCI / S&P 64.18% / 11.30% |
LosePOCI / S&P -30.00% / 27.70% |
| 2025-Q42/3 |
LosePOCI / S&P -3.68% / 2.65% |
WinPOCI / S&P 30.69% / 9.00% |
WinPOCI / S&P 41.54% / 13.40% |
| 2025-Q32/3 |
LosePOCI / S&P -11.22% / 8.12% |
WinPOCI / S&P 13.67% / 4.61% |
WinPOCI / S&P 33.33% / 13.45% |
| 2025-Q22/3 |
WinPOCI / S&P 18.07% / 10.94% |
LosePOCI / S&P -0.07% / 4.83% |
WinPOCI / S&P 68.00% / 10.63% |
| 2025-Q11/3 |
LosePOCI / S&P -13.90% / -4.27% |
LosePOCI / S&P -9.20% / 4.98% |
WinPOCI / S&P 221.43% / 10.57% |
| 2024-Q41/3 |
LosePOCI / S&P -13.62% / 2.41% |
LosePOCI / S&P -2.78% / 5.25% |
WinPOCI / S&P 116.67% / 6.15% |
| 2024-Q31/3 |
LosePOCI / S&P -5.42% / 5.89% |
LosePOCI / S&P -6.41% / 5.89% |
WinPOCI / S&P 687.50% / 6.11% |
| 2024-Q22/3 |
WinPOCI / S&P 6.31% / 4.28% |
LosePOCI / S&P -9.22% / 5.38% |
WinPOCI / S&P 1566.67% / 5.12% |
| 2024-Q10/3 |
LosePOCI / S&P -7.81% / 10.56% |
LosePOCI / S&P -6.73% / 5.71% |
LosePOCI / S&P -800.00% / 5.59% |
| 2023-Q40/3 |
LosePOCI / S&P 1.18% / 11.69% |
LosePOCI / S&P -5.87% / 6.81% |
LosePOCI / S&P -433.33% / 7.78% |
| 2023-Q32/3 |
WinPOCI / S&P -3.25% / -3.27% |
WinPOCI / S&P 10.06% / 7.52% |
LosePOCI / S&P -11.11% / -5.03% |
| 2023-Q21/3 |
LosePOCI / S&P -9.43% / 8.74% |
WinPOCI / S&P 34.23% / 9.50% |
LosePOCI / S&P -70.00% / -8.57% |
| 2023-Q12/3 |
WinPOCI / S&P 21.90% / 7.50% |
WinPOCI / S&P 53.52% / 10.77% |
LosePOCI / S&P -122.22% / -15.69% |
| 2022-Q41/3 |
LosePOCI / S&P -9.43% / 7.56% |
WinPOCI / S&P 79.65% / 11.88% |
LosePOCI / S&P -175.00% / -17.99% |
| 2022-Q32/3 |
WinPOCI / S&P 3.02% / -4.88% |
WinPOCI / S&P 79.72% / 13.47% |
LosePOCI / S&P POCI unavailable / -1.41% |
| 2022-Q22/3 |
WinPOCI / S&P -0.50% / -16.10% |
WinPOCI / S&P 46.87% / 13.71% |
LosePOCI / S&P POCI unavailable / 11.04% |
| 2022-Q11/3 |
LosePOCI / S&P -16.67% / -4.60% |
WinPOCI / S&P 32.42% / 15.97% |
LosePOCI / S&P POCI unavailable / 42.23% |
| 2021-Q41/3 |
WinPOCI / S&P 26.32% / 11.03% |
LosePOCI / S&P 11.92% / 15.00% |
LosePOCI / S&P POCI unavailable / 96.40% |
| 2021-Q31/3 |
WinPOCI / S&P 13.10% / 0.58% |
LosePOCI / S&P 0.86% / 10.77% |
LosePOCI / S&P POCI unavailable / 69.42% |
| 2021-Q21/3 |
LosePOCI / S&P 1.20% / 8.55% |
WinPOCI / S&P 7.57% / 6.58% |
LosePOCI / S&P POCI unavailable / 51.81% |
| 2021-Q12/3 |
WinPOCI / S&P 10.67% / 6.17% |
WinPOCI / S&P 1.71% / -1.06% |
LosePOCI / S&P POCI unavailable / 7.39% |
| 2020-Q42/3 |
WinPOCI / S&P 42.86% / 12.15% |
WinPOCI / S&P 11.86% / -3.72% |
LosePOCI / S&P POCI unavailable / -33.42% |
| 2020-Q31/3 |
LosePOCI / S&P -27.59% / 8.93% |
WinPOCI / S&P 31.01% / -2.04% |
LosePOCI / S&P POCI unavailable / -27.10% |
| 2020-Q21/3 |
LosePOCI / S&P 3.57% / 20.54% |
WinPOCI / S&P 45.84% / -0.46% |
LosePOCI / S&P POCI unavailable / -27.11% |
| 2020-Q11/3 |
LosePOCI / S&P -22.22% / -19.60% |
WinPOCI / S&P 71.07% / 3.47% |
LosePOCI / S&P POCI unavailable / -14.75% |
| 2019-Q42/3 |
WinPOCI / S&P 9.09% / 9.07% |
WinPOCI / S&P 73.46% / 5.36% |
LosePOCI / S&P POCI unavailable / 2.99% |
| 2019-Q32/3 |
WinPOCI / S&P 44.74% / 1.70% |
WinPOCI / S&P 69.84% / 5.02% |
LosePOCI / S&P POCI unavailable / 0.21% |
| 2019-Q21/3 |
LosePOCI / S&P -8.06% / 4.30% |
WinPOCI / S&P 68.50% / 6.64% |
LosePOCI / S&P POCI unavailable / 8.65% |
| 2019-Q11/3 |
LosePOCI / S&P -8.15% / 13.65% |
WinPOCI / S&P 78.47% / 8.12% |
LosePOCI / S&P POCI unavailable / 14.29% |
| 2018-Q41/3 |
LosePOCI / S&P -15.63% / -13.52% |
WinPOCI / S&P 47.64% / 9.05% |
LosePOCI / S&P 16.67% / 18.23% |
| 2018-Q32/3 |
WinPOCI / S&P 201.89% / 7.71% |
WinPOCI / S&P 37.05% / 10.21% |
LosePOCI / S&P -22.22% / 19.06% |
| 2018-Q21/3 |
LosePOCI / S&P -3.64% / 3.43% |
WinPOCI / S&P 28.01% / 9.03% |
LosePOCI / S&P -69.23% / 14.46% |
| 2018-Q11/3 |
WinPOCI / S&P 34.15% / -0.76% |
LosePOCI / S&P -2.93% / 7.68% |
LosePOCI / S&P -41.67% / 12.46% |
| 2017-Q40/3 |
LosePOCI / S&P -8.89% / 6.64% |
LosePOCI / S&P -0.27% / 7.03% |
LosePOCI / S&P -53.85% / 13.82% |
| 2017-Q30/3 |
LosePOCI / S&P -25.00% / 4.48% |
LosePOCI / S&P -14.69% / 5.68% |
LosePOCI / S&P -30.77% / 17.57% |
| 2017-Q21/3 |
WinPOCI / S&P 50.00% / 3.09% |
LosePOCI / S&P -19.46% / 4.83% |
LosePOCI / S&P -13.33% / 17.74% |
| 2017-Q10/3 |
LosePOCI / S&P -32.20% / 6.07% |
LosePOCI / S&P -13.27% / 3.67% |
LosePOCI / S&P -36.84% / 13.32% |
| 2016-Q40/3 |
LosePOCI / S&P 3.51% / 3.82% |
LosePOCI / S&P -9.27% / 2.09% |
LosePOCI / S&P -31.58% / 7.05% |
| 2016-Q31/3 |
WinPOCI / S&P 7.55% / 3.85% |
LosePOCI / S&P -0.81% / 0.20% |
LosePOCI / S&P -35.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | POCI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -5.74% | 20.78% |
| Annualized return | -5.74% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | POCI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -20.18% | 83.14% |
| Annualized return | -4.41% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | POCI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 110.95% | 319.30% |
| Annualized return | 7.75% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |